Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 210.73 --0 (-0%)
Previous Close $210.73    52 Week High $333.65 
Open $210.73    52 Week Low $223.02 
Day High $210.73    P/E 26.98 
Day Low $210.73    EPS $7.81 
Volume 37